Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion type Assertion NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_head.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion description "[While protection against BRCA1-associated breast cancer (HR = 0.61; 95% CI, 0.30 to 1.22) and BRCA2-associated gynecologic cancer (HR = 0.00; 95% CI, not estimable) was suggested, neither effect reached statistical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion evidence source_evidence_literature NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion SIO_000772 18268356 NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion wasDerivedFrom befree-2016 NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.
- NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_assertion wasGeneratedBy ECO_0000203 NP655005.RAIfpguAFcuIdnObl_BrKVy2P2f96fx8888rUonY-YAgY130_provenance.